mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.8 |
0.002 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.002 |